Choose the partnership that suits your needs and we will find solutions to support your strategy.
If you’ve got a solution that our audience needs to hear about, we’ve got the platform and expertise to position you correctly in front of the market. Get in touch by registering your interest below, or email Sam Sarwar at email@example.com
Raise Brand Awareness
Benefit from pre and post conference exposure to our AI community and increase market share through unique branding formats.
Meet and Network with Industry Pioneers
With a room full of drug developers looking to see how they can apply At into their pipelines, meet prospective clients during speed networking breaks, 1-2-1 meetings and more…
Generate Commercial Collaborations
Make sure your hottest prospects are in the room and part of the discussion, by having a wish-list of your choice contacted in advance of the event.
Benefit from Market Intelligence
Hear how and where pharmaceutical giants are looking to adopt and apply AI, enabling to match your solutions accordingly.
Position Yourself as an Industry Thought Leader
Pharma doors are now open to the idea of integrating AI programs. At this juncture it is crucial to stand out from the crowd. Demonstrate your expertise through podium presentations, moderating panel discussions or interactive roundtables.
Interested? Get in touch
Contact Sam Sarwar to discuss partnership opportunities. Call +44 203 141 8716, or email firstname.lastname@example.org
Enlitic, Inc. (“Enlitic”) is the world’s first medical deep learning company. For its unique algorithms, engineered from the ground up by renowned data scientists, machine learning practitioners, and medical experts, it was named one of the world’s “50 Smartest Companies” by MIT Tech Review. By combining medical images, texts, and other data, Enlitic’s technology leverages billions of clinical cases to accelerate pharmaceutical research and drug trials, drive clinical efficiencies, and improve diagnostic accuracy, speed and patient outcomes. Enlitic is headquartered in San Francisco, California.
e-therapeutics is an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology. Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.
Standigm builds artificial applicable intelligence in drug discovery and repositioning areas. We provide drug candidates and their treatment mechanisms predicted by our AI on huge datasets to partner pharmaceutical companies for development. StandigmAI satisfies not only predictability but also interpretability, physiology level candidate filtering and patent strategy through its sub AI components. Standigm now work together with five Korean partner companies and institutions for cancers, rheumatoid arthritis, Parkinson’s disease, autism and NASH respectively.